These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10900542)

  • 1. Studies of floating dosage forms of furosemide: in vitro and in vivo evaluations of bilayer tablet formulations.
    Ozdemir N; Ordu S; Ozkan Y
    Drug Dev Ind Pharm; 2000 Aug; 26(8):857-66. PubMed ID: 10900542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects.
    Yagi N; Kiuchi T; Satoh H; Terashima Y; Kenmotsu H; Sekikawa H; Takada M
    Biol Pharm Bull; 1996 Apr; 19(4):616-22. PubMed ID: 8860970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of sustained release floating drug delivery system for norfloxacin: in vitro and in vivo evaluation.
    Guguloth M; Bomma R; Veerabrahma K
    PDA J Pharm Sci Technol; 2011; 65(3):198-206. PubMed ID: 22293231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged-release hydroxypropyl methylcellulose matrix tablets of furosemide for administration to dogs.
    Smal J; Marvola M; Liljequist C; Happonen I
    J Vet Pharmacol Ther; 1996 Dec; 19(6):482-7. PubMed ID: 8971678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of a monolithic floating dosage form for furosemide.
    Menon A; Ritschel WA; Sakr A
    J Pharm Sci; 1994 Feb; 83(2):239-45. PubMed ID: 8169797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach.
    Otsuka K; Wagner C; Selen A; Dressman J
    J Pharm Pharmacol; 2015 May; 67(5):651-65. PubMed ID: 25644429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of a Single Experimental Design for the Optimization of Furosemide Modified-Release Tablet Formulations.
    Vlachou M; Siamidi A; Dotsikas Y
    Curr Drug Deliv; 2019; 16(10):931-939. PubMed ID: 31663479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of polymeric coated minitablets as multiple unit gastroretentive floating drug delivery systems for furosemide.
    Meka L; Kesavan B; Kalamata VN; Eaga CM; Bandari S; Vobalaboina V; Yamsani MR
    J Pharm Sci; 2009 Jun; 98(6):2122-32. PubMed ID: 19009598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability of furosemide from solution and 40 mg tablets with different dissolution characteristics following oral administration in normal men.
    Waller ES; Crismon ML; Smith RV; Bauza MT; Doluisio JT
    Biopharm Drug Dispos; 1988; 9(2):211-8. PubMed ID: 3370308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroretentive inorganic-organic hybrids to improve class IV drug absorption.
    Perioli L; Pagano C
    Int J Pharm; 2014 Dec; 477(1-2):21-31. PubMed ID: 25290811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N; Ordu S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of gastroretentive norfloxacin floating tablets.
    Bomma R; Swamy Naidu RA; Yamsani MR; Veerabrahma K
    Acta Pharm; 2009 Jun; 59(2):211-21. PubMed ID: 19564145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers.
    Xu X; Sun M; Zhi F; Hu Y
    Int J Pharm; 2006 Mar; 310(1-2):139-45. PubMed ID: 16413710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique: in vitro and in vivo evaluation in healthy volunteers.
    Hu L; Li L; Yang X; Liu W; Yang J; Jia Y; Shang C; Xu H
    Eur J Pharm Sci; 2011 Jan; 42(1-2):99-105. PubMed ID: 21050887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacokinetic-pharmacodynamic relationship and in vitro equivalence of two oral furosemide tablet formulations.
    Cuadrado A; Rodríguez Gascón A; Hernández RM; Castilla AM; de la Maza A; Yánez C; López de Ocáriz A; Solinís MA; Pedraz JL
    Arzneimittelforschung; 2003; 53(5):321-9. PubMed ID: 12854359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and in-vitro evaluation of floating bilayer tablet of lisinopril maleate and metoprolol tartrate.
    Ijaz H; Qureshi J; Danish Z; Zaman M; Abdel-Daim M; Hanif M; Waheed I; Mohammad IS
    Pak J Pharm Sci; 2015 Nov; 28(6):2019-25. PubMed ID: 26639495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers.
    Reddy AB; Reddy ND
    Drug Res (Stuttg); 2017 Jul; 67(7):412-418. PubMed ID: 28449156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.